Biocontrol Technology's hyperthermia treatment for AIDS to undergo 30-patient trial.
This article was originally published in The Gray Sheet
Executive Summary
WHOLE-BODY EXTRACORPOREAL HYPERTHERMIA TREATMENT FOR AIDS patients will be tested in a 30-patient study at St. Elizabeth's Hospital in Lafayette, Indiana under a recently cleared FDA protocol. Sponsored by Biocontrol Technology, Inc.'s subsidiary IDT, located in Pittsburgh, Pennsylvania, the study will assess the effects of heating a patient's blood to 107.6 F using the BioLogic-HT System, which is manufactured by HemoCleanse, also of Lafayette.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.